SOPHiA GENETICS’s $77 Million Series E Investment Round

Paolo Bossi

SOPHiA GENETICS, a leading Swiss health tech company, closed a $77 million Series E investment round. The round was led by Generation Investment Management, a pioneer…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now